Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 18, 2026.

Iron at the interface of immunity and infection

Manfred Nairz, David Haschka, Egon Demetz and 1 more

Frontiers in Pharmacology · 2014 · Review

doi:10.3389/fphar.2014.00152

Abstract

Both, mammalian cells and microbes have an essential need for iron, which is required for many metabolic processes and for microbial pathogenicity. In addition, cross-regulatory interactions between iron homeostasis and immune function are evident. Cytokines and the acute phase protein hepcidin affect iron homeostasis leading to the retention of the metal within macrophages and hypoferremia. This is considered to result from a defense mechanism of the body to limit the availability of iron for extracellular pathogens while on the other hand the reduction of circulating iron results in the development of anemia of inflammation. Opposite, iron and the erythropoiesis inducing hormone erythropoietin affect innate immune responses by influencing interferon-gamma (IFN-γ) mediated (iron) or NF-kB inducible (erythropoietin) immune effector pathways in macrophages. Thus, macrophages loaded with iron lose their ability to kill intracellular pathogens via IFN-γ mediated effector pathways such as nitric oxide (NO) formation. Accordingly, macrophages invaded by the intracellular bacterium Salmonella enterica serovar Typhimurium increase the expression of the iron export protein ferroportin thereby reducing the availability of iron for intramacrophage bacteria while on the other side strengthening anti-microbial macrophage effector pathways via increased formation of NO or TNF-α. In addition, certain innate resistance genes such as natural resistance associated macrophage protein function (Nramp1) or lipocalin-2 exert part of their antimicrobial activity by controlling host and/or microbial iron homeostasis. Consequently, pharmacological or dietary modification of cellular iron trafficking enhances host resistance to intracellular pathogens but may increase susceptibility to microbes in the extracellular compartment and vice versa. Thus, the control over iron homeostasis is a central battlefield in host-pathogen interplay influencing the course of an infectious disease in favor of either the mammalian host or the pathogenic invader.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

INTRODUCTION

The control over iron homeostasis is decisive in host–pathogen interaction. This is due to the fact that iron is central for several metabolic processes for both, prokaryotic and eukaryotic cells that the metal affects microbial proliferation and pathogenicity and in addition significantly impacts on immune cell plasticity and innate immune responses. These multiple functional aspects of iron are based on its ability to transfer electrons needed during metabolic processes and to catalyze the formation of highly reactive radicals. The latter can act as signaling molecules but also intoxicate microbes or damage surrounding cells and tissues. Many microbes are highly dependent on a sufficient supply of iron and take up this metal by multiple and divergent pathways or steel it from iron deposition sites of the host. The activation and expression of such microbial iron acquisition systems is linked to their pathogenicity and proliferation. On the other hand, iron plays important roles in anti-microbial host responses, first by synergistic effects towards anti-microbial radical formation but second, by directly altering immune cell proliferation and anti-microbial immune effector pathways. Thus, the host immune system affects the availability of iron for microbes via the activity of cytokines, cellular proteins/peptides and hormones to gain control over pathogen proliferation and to strengthen specific immune effector pathways, a strategy for which the term “nutritional immunity has been coined.

ALTERATION OF IRON HOMEOSTASIS DURING INFECTION AND INFLAMMATION

The most frequent and best known example visualizing the interaction between iron, immunity and infection is anemia of chronic disease (ACD) also termed as anemia of (chronic) inflammation. ACD is considered to be the second most frequent anemia worldwide and it develops specifically in patients suffering from chronic inflammatory diseases, such as auto-immune disorders, cancer, chronic infections or in patients undergoing dialysis. The underlying pathophysiology involves mainly (i) iron retention within the monocyte/macrophage system, (ii) a blunted formation and activity of the red blood cell hormone erythropoietin (Epo), and (iii) an impaired proliferation and differentiation of erythroid progenitor cells. All these pathophysiological pathways are driven by inflammatory signals, and the mononuclear-phagocyte system (MPS) is in the center of such alterations. Specifically, macrophages are of central importance for maintaining a sufficient supply of iron for erythropoiesis due to their role in iron re-utilization from senescent erythrocytes which are taken up by these immune cells by a process called erythrophagocytosis before being degraded leading to recovery of heme which is further processed by the enzyme heme oxygenase-1 (HO-1) yielding equal amounts of iron, biliverdin and carbon-monoxid. Under physiological conditions iron recycling by macrophages accounts for approximately 95% of the daily needs of the metal for erythropoiesis and other physiological processes. However, during inflammation this process is blunted resulting in an impaired delivery of iron for erythropoiesis. Thereby, cytokines and acute-phase proteins affect body iron homeostasis and macrophage iron metabolism leading to an inflammation driven diversion of iron traffic which is characterized by low circulating iron concentrations and high levels of the iron storage protein ferritin, the latter reflecting iron retention in the MPS.

In case of an infection, auto-immune disease or cancer immune cells are activated and produce a myriad of cytokines, some of which exerting specific effects on iron homeostasis. Cytokines such as interleukin (IL)-1, IL-6, or IL-22 as well as bacterial LPS or endoplasmic reticulum stress induce the formation of the master regulator of iron homeostasis, hepcidin, in the liver. Hepcidin affects cellular iron homeostasis upon binding to the only known iron export protein ferroportin, thereby leading to ferroportin internalization and degradation which subsequently reduces cellular iron export. As a consequence of this interaction, the absorption of iron from the diet is reduced due to hepcidin mediated reduction of ferroportin expression in enterocytes, thereby resulting in a reduction of circulating iron levels which is further aggravated by the inhibition of iron export from macrophages by the same mechanism. Moreover, macrophages produce minute amounts of hepcidin in response to inflammatory stimuli such as IL-6 or LPS thereby blocking iron export in an autocrine fashion, which is meant to result from a nutritional immune strategy of the body to reduce the availability of iron for extracellular pathogens (Figure 1).

In parallel, cytokines exert subtle and hepcidin independent effects on the regulation of iron homeostasis on multiple levels. First, tumor necrosis factor-alpha (TNF-α) impairs duodenal iron absorption by an as yet not fully elucidated mechanism. Second, TNF-α, IL-1, IL-6, and interferon-gamma (IFN-γ) affect macrophage iron homeostasis by different avenues. They increase the uptake of transferrin and non-transferrin bound iron by modulating the expression of transferrin receptor-1 and divalent metal transporter-1, respectively. In parallel, based on damaging of erythrocytes by inflammation born radicals, the half-life of erythrocytes decreases and erythrophagocytosis is stimulated. In addition, many of these cytokines as well as the anti-inflammatory cytokines IL-4, IL-10, and IL-13 promote efficient iron storage within macrophages/monocytes by increasing the expression of ferritin, both at the transcriptional and posttranscriptional level. Macrophage iron content is further expanded via an inhibitory effect of IFN-γ and LPS on ferroportin transcription thereby reducing cellular iron egress.

In summary the combination of these regulatory effects lead to iron retention in circulating monocytes and macrophages which present with low ferroportin expression and increased intracellular ferritin levels along with a reduction of circulating iron concentration, the diagnostic hallmark of ACD.

INTERRELATIONSHIP BETWEEN IRON AVAILABILITY, INNATE IMMUNE FUNCTION AND CONTROL OF INFECTIONS

Considering the prevalence of ACD the question arises whether there is a specific benefit for the host upon development of ACD. Obviously, the retention of iron in the monocyte–macrophage system reduces circulating iron levels and thus the availability of this essential nutrient for extracellular microbes (Figure 1A). This iron withholding strategy appears to be of benefit to combat infections with circulating microbes or pathogens residing in tissues with high iron contents such as the liver. In addition, the pathophysiological mechanisms underlying the development of ACD also significantly impact on the efficacy of host responses against infections. First, the reduced biological activity of Epo may ameliorate anti-bacterial immune responses. This is based on the fact that the major erythropoiesis stimulating hormone Epo also exerts effects on cells and tissues outside the bone marrow, and such effects are transduced by a heterodimeric receptor which differs from the receptor expressed on erythroid progenitor cells. Thereby, Epo inhibits pro-inflammatory immune effector pathways in macrophages via inhibition of NF-kB activation which results in reduced expression of inducible nitric oxide synthase (iNOS), TNF-α, IL-6, and IL-12 by inflammatory macrophages and an impaired immune control of infections with bacteria such as Salmonella enterica serovar typhimurium (S. typhimurium; ). Accordingly, the reduced Epo activity observed in ACD results in a sustained pro-inflammatory immune response and an improved control of S. typhimurium septicemia. Second, iron exerts multiple effects on immune effector functions. This is on the one hand based on the role of iron for the differentiation and proliferation of immune cells, including antigen presenting cells and lymphocytes (reviewed by;; ). Moreover, iron affects anti-microbial immune function of macrophages via inhibition of IFN-γ inducible effector pathways. Thus, macrophages loaded with iron lose their ability to clear infections with intracellular pathogens, such as Salmonella, Mycobacteria, Chlamydia, Candida, or Legionella whereas reduction of iron levels or addition of iron chelators can improve infection control by withholding iron from microbes and by increasing anti-microbial immune effector functions. Thereby iron chelators antagonize a direct inhibitory effect of iron toward the expression of iNOS. iNOS catalyzed high output formation of the labile radical NO by macrophages which exerts direct anti-microbial effector functions. This pathway appears to be partly responsible for the beneficial clinical effects of iron chelators observed in several experimental infection systems. Along this line children suffering from cerebral malaria benefited from the addition of the iron chelator desferrioxamine to a standard anti-malaria treatment, as reflected by faster recurrence from coma and clearance of plasmodia, although this did not translate into a survival benefit, although anti-plasmodial innate immune responses were positively affected by iron chelation in vivo. Of interest, via its inhibitory potential on IFN-γ iron affects T-helper (TH) cell differentiation favoring the expansion of TH-2 cells which produce a number of macrophage-deactivating cytokines such as IL-4 or IL-13. Accordingly, iron overload and iron chelation have been shown to modulate the TH-1/TH-2 in mice exposed to different microbes. However, a recent clinical trial in patients after allogenic bone marrow transplantation who received the iron chelator desferrasirox in an attempt to improve the control of mucormycosis, a devastating invasive fungal infection in severely immuno-compromised patients, failed to show a clinical benefit. In contrast, the mortality rate was even higher in those subjects receiving desferrasirox and the reason for that has been elusive thus far. Hypothetically this may be partly related to an effect of desferrasirox on innate immune function, which could have been resulted in aggravation of graft versus host disease, a notion which should be verified at least retrospectively.

However, from all the evidence listed above it appears obvious that ACD develops from the endeavor of the body to withhold iron from invading, extracellular pathogens and to strengthen at the same time anti-microbial immune responses (Figure 1A).

Accordingly, clinical trials which were performed to supplement iron to children in developing countries based on the notion that iron deficiency is associated with growth and mental retardation produced unpredicted results. These studies demonstrated that iron supplementation resulted in higher incidence of or higher mortality from infections such as malaria, diarrhea or bacterial meningitis. The pathways underlying these devastating outcomes remain elusive thus far. However, they may be linked to iron mediated modulation of anti-microbial immune defense mechanisms or traced back to increased availability of the metal for pathogens in the setting of subclinical parasitemia or bacteremia. The cause-effective association between iron availability and the clinical course of malaria has been well established by several recent studies.

Those studies provided evidence for a reduced risk of malaria in general and severe malaria in iron deficient pregnant women and children whereas other studies found interesting associations between iron delivery for erythropoiesis, circulating hepcidin levels and the prevalence of malaria in tropical countries.

Apart from plasmodia, the availability of iron is of importance for other parasitic infection such as Leishmaniosis or Trypanosomiasis. The pathogenicity of Leishmania is linked to the expression of different microbial iron acquisition molecules and a sufficient supply of iron. Accordingly, inhibition of cellular iron export can promote Leishmania proliferation whereas over-expression of ferroportin with subsequent limitation of intracellular iron availability limits intracellular leishmanial growth. In addition, drugs such as quercetin exert their anti-microbial activity against Leishmania donovani by interfering with microbial iron acquisition. Of note, L. donovani manipulates macrophage iron homeostasis to increase its own iron supply. However, via its radical promoting capacity iron can also exert protective effects in Leishmania infection by strengthening radical dependent host response as shown in a mouse model of Leishmania infantum infection. Similarly, Trypanosma species are also highly dependent on a sufficient supply of iron which depending on the subtype is acquired by classical sources (transferrin) or taken up via ZIP family transporters. Given the central role of iron for the pathogenesis of trypansoma infections, the host aims at limiting iron availability to these parasites which results in alterations of macrophage iron homeostasis along with the development of anemia. Of interest, the induction of the Nrf2 pathway exerted protective effects in a model of Trypanosma cruci infection in mice which was counterbalanced by the addition of iron sulfate, suggesting that Nrf2 exerted its anti-trypanosmal activity by increasing the expression of ferroportin.

METABOLIC IRON RESPONSES AND IMMUNE CONTROL OF INTRACELLULAR PATHOGENS

Although still insufficiently understood, it is hypothesized that the presence of extracellular pathogens in the circulation induces iron restriction in the monocyte/macrophage system via the action of hepcidin and several cytokines, whereas the metabolic responses to intracellular microbes appear to be different (Figure 1). Macrophages infected with S. typhimurium increase the expression of ferroportin and stimulate iron export. This leads to a reduced availability of iron for intracellular bacteria along with an activation of anti-microbial immune effector mechanisms due to counter-balancing the negative regulatory effects of iron on IFN-γ inducible immune pathways. Similar observations have been made with other intracellular pathogens such as Chlamydia spp. or Legionella Of interest, ferroportin is also expressed in mycobacteria containing phagosomes where it pumps iron into the cytoplasma, a pathway which limits the availability of this essential nutrient for this bacterium. This indicates that the stimulation of iron export via ferroportin is an efficient defense strategy against infection with intracellular microbes by limiting their access to iron and by strengthening anti-microbial immune effector pathways.

Recent evidence suggest, that the intracellular bacterium Salmonella typhimurium can counteract these metabolic immune defense strategies by inducing hepcidin expression in hepatocytes via activation of estrogen related receptor (ERR)-gamma, thereby resulting in hypoferremia and macrophage iron retention with a subsequently increased availability of the metal for intracellular Salmonella. A reverse agonist of this pathway counter-acting ERR-gamma and hepcidin mediated macrophage iron retention led to an improved control of Salmonella infection. This is in a line with previous observations demonstrating that modulation of the hepcidin/ferroportin axis impacts on intracellular proliferation of Salmonella and the course of infection in mice.

Importantly, several innate resistance mechanisms exert at least part of their anti-microbial activity via restriction of iron to microbes.

NO

High output formation of NO by immune cells is of central importance for immune control of infections and cancer. An interaction of NO with iron homeostasis has been well documented based on the fact that (i) NO has a high affinity for iron and that many of the cytotoxic effects of NO are based on targeting of central iron sulfur clusters in enzymes by the labile radical, that (ii) NO controls intracellular iron trafficking by regulating the binding affinity of iron regulatory proteins (IRP) to specific RNA stem loop structures within the non-coding regions of critical iron metabolism genes, and finally, that (iii) cellular iron content controls NO expression by regulating iNOS transcription. Recent evidence now suggests that part of the anti-microbial effect of NO can be attributed to a regulatory activity of the radical on iron homeostasis. Thereby, NO activates the binding affinity of the transcription factor Nrf-2 to the ferroportin promoter, resulting in increased ferroportin expression and iron export. This results in a reduced availability of iron for intra-macrophage bacteria and a strengthening of anti-microbial, IFN-γ driven immune responses. Of note, iNOS-/- mice present with macrophage iron overload and their resistance against infection with Salmonella can be increased upon application of a membrane permeable iron chelator such as desferrasirox.

Nramp1

The natural resistance macrophage protein 1 (Nramp1 or Slc11a1) has been characterized as a late phagosomal protein conferring resistance to infection with Salmonella, Mycobacteria, and Leishmania. Nramp1 exerts its protective effect against such infections via acidification of the microbe containing phagosome, but also by altering the cellular distribution of divalent metals such as zinc, manganese or iron which all play decisive role in host–pathogen interaction. In addition, the functional expression of Nramp1 strengthens anti-microbial immune effector pathways such as the formation of TNF-α or NO. These effects can be traced back to prolonged activity of pro-inflammatory signaling pathways and inhibition of the expression of anti-inflammatory cytokines, such as IL-10. Evidence accumulates, that Nramp1pumps iron out of macrophages thereby reducing iron levels in the cytoplasma and within the phagolysosome rendering the metal less available for intracellular bacteria. As a further consequence of intracellular iron depletion, pro-inflammatory immune effector pathways are augmented. One of these Nramp1-inducible responses is the increased formation of lipocalin-2 (Lcn2 or NGAL), which blocks another source of iron for bacteria.

LIPOCALIN-2

Lcn2 is produced by several cells in the body including neutrophils and macrophages. Among many other functions it binds the bacterial siderophore enterobactin, which is produced by Gram-negative bacteria such as Escherichia coli, Klebsiella, or Salmonella spp. to scavenge iron and to redeliver the metal to the microbe where it is taken up via specific receptors. Mice expressing Lcn2 are more resistant to infections with such Gram-negative bacteria as compared to Lcn2-/- littermates which is cause-effectively due to the bacterial iron withholding capacity of Lcn2. Of note, the varying dependence of bacteria from siderophore mediated iron uptake can cause a growth advantage of certain bacteria among others. It has recently been demonstrated that the pro-biotic bacterium E. coli Nissle controls the growth of pathogenic Salmonella in the intestine by over-coming iron restriction by Lcn2. Accordingly, resistance of Salmonella to Lcn2 mediated iron restriction can cause a growth advantage of this pathogen in the gut. It is of interest, that Lcn2 not only affects microbial iron delivery but also host iron homeostasis. This is most likely due to binding of a recently identified mammalian siderophore by Lcn2 which then can shuttle iron across cellular membranes. Of note, recent evidence also suggests that the mammalian siderophore 2,5-DHBA can be utilized by Gram-negative bacteria as a source of iron and that macrophages reduce the expression of 2,5-DHBA when exposed to LPS or Gram negative bacteria which is also considered to be part of the “iron withholding” defense network of innate immune cells.

Lcn2 appears to be of importance to mount alterations of iron host homeostasis on the cellular and systemic level thereby contributing to hypoferremia and intracellular iron depletion in systemic Salmonella infection. An increased expression of Lcn2 by macrophages along with reduced intramacrophage iron content and impaired bone morphogenetic signaling may be largely responsible for the reduced susceptibility of Hfe-/- mice, a model for hereditary hemochromatosis, against infection with the intracellular bacteria Salmonella and Mycobacteria, which may also be a reason of the high penetrance of this genes in people of Northern and Western European origin. Accordingly, Lcn2 expression positively affects the course of infection with other intracellular pathogens, even if they do not express siderophores such as Chlamydia, whereas cellular iron export and increased delivery of the metal to the extracellular space can be detrimental as observed in a model of pneumococcal infection, where Lcn2 expression by neutrophils resulted in increased mortality of mice.

This again provides evidence that contrasting pathways for the regulation of iron homeostasis according to infection with either intracellular or extracellular pathogens exist which are still insufficiently understood (Figure 1).

Owing to the importance of these pathways for immune defense against infection with intracellular pathogens the central TH-1 cytokine IFN-γ exerts part of its anti-microbial effects by stimulating immune responses which restrict the availability of iron for microbes. IFN-γ induces the expression of Nramp1, Lcn2, and NO thereby reducing intracellular iron content in macrophages and limiting the growth of bacteria such as Salmonella. Thus, IFN-γ is central for host response in Salmonella infection based on these nutritional iron effects but also due to its ability to induce a myriad of anti-bacterial effector mechanisms in macrophages including oxygen and nitrogen radical formation or maturation of the bacterial containing phagosome. Of note, neutrophils have recently been shown to produce IFN-γ to further stimulate anti-bacterial immune pathways whereas S. typhimurium has been shown to impair the proliferation of CD4 cells, a major source of IFN-γ.

TARGETING IRON HOMEOSTASIS IN INFECTIOUS DISEASE-TO WALK A TIGHTROPE

While iron supplementation in eras with a higher burden of infectious diseases caused detrimental effects toward the risk of malaria or invasive bacterial infections, iron supplementation in HIV infected patients resulted in an impaired control of malaria but also in a beneficial or at least neutral course of HIV infection at as reflected by CD4+-cell counts or progression of the disease which was partly dependent on the degree of anemia and base-line iron status. However, HIV infection is often associated with reactivation of Mycobacterium tuberculosis infection, and iron has been shown to be an essential nutrient for such bacteria which goes along with the observation that iron loading is associated with an increased risk for tuberculosis and an adverse clinical course of this infection. Accordingly, iron supplementation in subjects with latent tuberculosis and an impaired immune control, e.g., on the basis of HIV infection, is hazardous. Of interest, a recent study suggested that both, iron deficiency and iron loading, are associated with an adverse clinical course of tuberculosis, both in HIV positive and negative subjects. This may relate to the divergent effects of iron on the immune system, on the one hand iron is a prerequisite for immune cell proliferation and differentiation, and a catalyzer for the formation of anti-microbial radicals, whereas on the other hand it impacts on innate immune effector functions and positively affects microbial proliferation (;;;; Figure 1B). Thus, a certain balance of iron, not too less and not too much, is needed to strengthen immune responses to successfully combat infections. Of note, alterations of iron homeostasis have been shown to affect the composition of the human microbiome and may thereby alter the proliferation of pathogenic bacteria.

Accordingly, pharmacological concepts to modify iron homeostasis and iron trafficking in an attempt to combat infection have always to keep in mind that a positive effect on one infection may have devastating effects on the course of another infection as seen in models of malaria where tolerance induction via overexpression of HO improves the course of malaria but increases the risk for bacterial infections such as Salmonellosis. Opposite, reduction of intracellular/macrophage iron levels upon therapeutic application of the calcium-antagonists nifedipine resulted in significantly improved survival of mice with S. typhimurium. Strictly speaking, any therapeutic strategy, e.g., iron chelation, iron mobilization, hepcidin or anti-hepcidin pharmacological approaches, which help to control the course of one, e.g., intracellular infection, may increase the availability of iron for a pathogen residing in a different compartment, e.g., in the extracellular space, along with the unpredictable effects on host immune response. Thus, major research efforts must be undertaken to better understand the diverse roles of iron in infection and in immune control of infections. Specifically, we also need to address the metabolic alterations of iron homeostasis in response to different pathogens, not only in terms of their primary tissue localization but also in relation to their needs for iron and the immune mechanisms being involved in their control.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 148

  1. 1.

    Andrews-Polymenis H. L. Baumler A. J. McCormick B. A. Fang F. C. (2010 ). Taming the elephant: Salmonella biology, pathogenesis, and prevention. Infect. Immun. 78 2356–2369

    Not in our library10.1128/iai.00096-10

  2. 2.

    Armitage A. E. Eddowes L. A. Gileadi U. Cole S. Spottiswoode N. Selvakumar T. A. (2011 ). Hepcidin regulation by innate immune and infectious stimuli. Blood 118 4129–4139

    Not in our library10.1182/blood-2011-04-351957

  3. 3.

    Arosio P. Levi S. (2002 ). Ferritin, iron homeostasis, and oxidative damage. Free. Radic. Biol. Med. 33 457–463

    Not in our library10.1016/s0891-5849(02)00842-0

  4. 4.

    Atif S. M. Winter S. E. Winter M. G. McSorley S. J. Baumler A. J. (2014 ). Salmonella enterica serovar Typhi impairs CD4 T cell responses by reducing antigen availability. Infect. Immun. 82 2247–2254

    Not in our library10.1128/iai.00020-14

  5. 5.

    Atkinson S. H. Armitage A. E. Khandwala S. Mwangi T. W. Uyoga S. Bejon P. A. (2014 ). Combinatorial effects of malaria season, iron deficiency and inflammation determine plasma hepcidin concentration in African children. Blood 123 3221–3229

    Not in our library10.1182/blood-2013-10-533000

  6. 6.

    Bao G. Clifton M. Hoette T. M. Mori K. Deng S. X. Qiu A. (2010 ). Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 6 602–609

    Not in our library10.1038/nchembio.402

  7. 7.

    Barton C. H. Biggs T. E. Baker S. T. Bowen H. Atkinson P. G. (1999 ). Nramp1: a link between intracellular iron transport and innate resistance to intracellular pathogens. J. Leukoc. Biol. 66 757–762

    Not in our library10.1002/jlb.66.5.757

  8. 8.

    Barton C. H. Whitehead S. H. Blackwell J. M. (1995 ). Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1 267–279

    Not in our library

  9. 9.

    Bellmann-Weiler R. Martinz V. Kurz K. Engl S. Feistritzer C. Fuchs D. (2010 ). Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma. Immunobiology 215 842–848

    Not in our library10.1016/j.imbio.2010.05.021

  10. 10.

    Bellmann-Weiler R. Schroll A. Engl S. Nairz M. Talasz H. Seifert M. (2013 ). Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology 218 969–978

    Not in our library10.1016/j.imbio.2012.11.004

  11. 11.

    Ben-Othman R. Flannery A. R. Miguel D. C. Ward D. M. Kaplan J. Andrews N. W. (2014 ). Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. PLoS Pathog. 10:e1003901

    Not in our library10.1371/journal.ppat.1003901

  12. 12.

    Berger T. Togawa A. Duncan G. S. Elia A. J. You-Ten A. Wakeham A. (2006 ). Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 103 1834–1839

    Not in our library10.1073/pnas.0510847103

  13. 13.

    Blackwell J. M. Searle S. Goswami T. Miller E. N. (2000 ). Understanding the multiple functions of Nramp1. Microbes Infect. 2 317–321

    Not in our library10.1016/s1286-4579(00)00295-1

  14. 14.

    Bogdan C. (2001 ). Nitric oxide and the immune response. Nat. Immunol. 2 907–916

    Not in our library10.1038/ni1001-907

  15. 15.

    Botella H. Stadthagen G. Lugo-Villarino G. de Chastellier C. Neyrolles O. (2012 ). Metallobiology of host–pathogen interactions: an intoxicating new insight. Trends Microbiol. 20 106–112

    Not in our library10.1016/j.tim.2012.01.005

  16. 16.

    Brines M. Cerami A. (2012 ). The receptor that tames the innate immune response. Mol. Med. 18 486–496

    Not in our library10.2119/molmed.2011.00414

  17. 17.

    Byrd T. F. Horwitz M. A. (1993 ). Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J. Clin. Invest. 91 969–976

    Not in our library10.1172/jci116318

  18. 18.

    Cairo G. Recalcati S. Mantovani A. Locati M. (2011 ). Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 32 241–247

    Not in our library10.1016/j.it.2011.03.007

  19. 19.

    Cartwright G. E. (1966 ). The anemia of chronic disorders. Semin. Hematol. 3 351–375

    Not in our library

  20. 20.

    Cassat J. E. Skaar E. P. (2013 ). Iron in infection and immunity. Cell Host Microbe 13 509–519

    Not in our library10.1016/j.chom.2013.04.010

  21. 21.

    Chan Y. R. Liu J. S. Pociask D. A. Zheng M. Mietzner T. A. Berger T. (2009 ). Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J. Immunol. 182 4947–4956

    Not in our library10.4049/jimmunol.0803282

  22. 22.

    Chakraborty S. Kaur S. Guha S. Batra S. K. (2012 ). The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta 1826 129–169

    Not in our library10.1016/j.bbcan.2012.03.008

  23. 23.

    Chlosta S. Fishman D. S. Harrington L. Johnson E. E. Knutson M. D. Wessling-Resnick M. (2006 ). The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74 3065–3067

    Not in our library10.1128/iai.74.5.3065-3067.2006

  24. 24.

    Corradini E. Garuti C. Montosi G. Ventura P. Andriopoulos B. Jr. Lin H. Y. (2009 ). Bone morphogenetic protein signaling is impaired in a Hfe knockout mouse model of hemochromatosis. Gastroenterology 137 1489–1497

    Not in our library10.1053/j.gastro.2009.06.057

  25. 25.

    Crouch M. L. Castor M. Karlinsey J. E. Kalhorn T. Fang F. C. (2008 ). Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 67 971–983

    Not in our library10.1111/j.1365-2958.2007.06089.x

  26. 26.

    Das N. K. Biswas S. Solanki S. Mukhopadhyay C. K. (2009 ). Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol. 11 83–94

    Not in our library10.1111/j.1462-5822.2008.01241.x

  27. 27.

    Delaby C. Pilard N. Hetet G. Driss F. Grandchamp B. Beaumont C. (2005 ). A physiological model to study iron recycling in macrophages. Exp. Cell Res. 310 43–53

    Not in our library10.1016/j.yexcr.2005.07.002

  28. 28.

    de Mast Q. Syafruddin D. Keijmel S. Riekerink T. O. Deky O. Asih P. B. (2010 ). Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 95 1068–1074

    Not in our library10.3324/haematol.2009.019331

  29. 29.

    Deriu E. Liu J. Z. Pezeshki M. Edwards R. A. Ochoa R. J. Contreras H. (2013 ). Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14 26–37

    Not in our library10.1016/j.chom.2013.06.007

  30. 30.

    Devireddy L. R. Hart D. O. Goetz D. H. Green M. R. (2010 ). A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in Enterobactin production. Cell 141 1006–1017

    Not in our library10.1016/j.cell.2010.04.040

  31. 31.

    Diaz-Ochoa V. E. Jellbauer S. Klaus S. Raffatellu M. (2014 ). Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect. Microbiol. 4:2

    Not in our library10.3389/fcimb.2014.00002

  32. 32.

    Dlaska M. Weiss G. (1999 ). Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162 6171–6177

    Not in our library

  33. 33.

    Drakesmith H. Prentice A. M. (2012 ). Hepcidin and the iron-infection axis. Science 338 768–772

    Not in our library10.1126/science.1224577

  34. 34.

    Drapier J. C. Hirling H. Wietzerbin J. Kaldy P. Kuhn L. C. (1993 ). Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12 3643–3649

    Not in our library10.1002/j.1460-2075.1993.tb06038.x

  35. 35.

    Esan M. O. van Hensbroek M. B. Nkhoma E. Musicha C. White S. A. Ter Kuile F. O. (2013 ). Iron supplementation in HIV-infected Malawian children with anemia: a double-blind, randomized, controlled trial. Clin. Infect. Dis. 57 1626–1634

    Not in our library10.1093/cid/cit528

  36. 36.

    Esposito B. P. Breuer W. Sirankapracha P. Pootrakul P. Hershko C. Cabantchik Z. I. (2003 ). Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102 2670–2677

    Not in our library10.1182/blood-2003-03-0807

  37. 37.

    Fahmy M. Young S. P. (1993 ). Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem. J. 296(Pt 1) 175–181

    Not in our library10.1042/bj2960175

  38. 38.

    Fang F. C. Weiss G. (2014 ). Iron ERRs with Salmonella. Cell Host Microbe 15 515–516

    Not in our library10.1016/j.chom.2014.04.012

  39. 39.

    Flo T. H. Smith K. D. Sato S. Rodriguez D. J. Holmes M. A. Strong R. K. (2004 ). Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 917–921

    Not in our library10.1038/nature03104

  40. 40.

    Forbes J. R. Gros P. (2001 ). Divalent-metal transport by NRAMP proteins at the interface of host–pathogen interactions. Trends Microbiol. 9 397–403

    Not in our library10.1016/s0966-842x(01)02098-4

  41. 41.

    Frawley E. R. Crouch M. L. Bingham-Ramos L. K. Robbins H. F. Wang W. Wright G. D. (2013 ). Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 110 12054–12059

    Not in our library10.1073/pnas.1218274110

  42. 42.

    Fritsche G. Dlaska M. Barton H. Theurl I. Garimorth K. Weiss G. (2003 ). Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J. Immunol. 171 1994–1998

    Not in our library10.4049/jimmunol.171.4.1994

  43. 43.

    Fritsche G. Larcher C. Schennach H. Weiss G. (2001 ). Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J. Infect. Dis. 183 1388–1394

    Not in our library10.1086/319860

  44. 44.

    Fritsche G. Nairz M. Libby S. J. Fang F. C. Weiss G. (2012 ). Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar Typhimurium in macrophages via stimulation of lipocalin-2 expression. J. Leukoc. Biol. 92 353–359

    Not in our library10.1189/jlb.1111554

  45. 45.

    Fritsche G. Nairz M. Werner E. R. Barton H. C. Weiss G. (2008 ). Nramp1-functionality increases iNOS expression via repression of IL-10 formation. Eur. J. Immunol. 38 3060–3067

    Not in our library10.1002/eji.200838449

  46. 46.

    Gangaidzo I. T. Moyo V. M. Mvundura E. Aggrey G. Murphree N. L. Khumalo H. (2001 ). Association of pulmonary tuberculosis with increased dietary iron. J. Infect. Dis. 184 936–939

    Not in our library10.1086/323203

  47. 47.

    Ganz T. (2009 ). Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21 63–67

    Not in our library10.1016/j.coi.2009.01.011

  48. 48.

    Gordeuk V. Thuma P. Brittenham G. McLaren C. Parry D. Backenstose A. (1992 ). Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327 1473–1477

    Not in our library10.1056/nejm199211193272101

  49. 49.

    Gozzelino R. Andrade B. B. Larsen R. Luz N. F. Vanoaica L. Seixas E. (2012 ). Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12 693–704

    Not in our library10.1016/j.chom.2012.10.011

  50. 50.

    Gruenheid S. Pinner E. Desjardins M. Gros P. (1997 ). Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185 717–730

    Not in our library10.1084/jem.185.4.717

  51. 51.

    Gwamaka M. Kurtis J. D. Sorensen B. E. Holte S. Morrison R. Mutabingwa T. K. (2012 ). Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 54 1137–1144

    Not in our library10.1093/cid/cis010

  52. 52.

    Henard C. A. Vazquez-Torres A. (2011 ). Nitric oxide and Salmonella pathogenesis. Front. Microbiol. 2:84

    Not in our library10.3389/fmicb.2011.00084

  53. 53.

    Hentze M. W. Muckenthaler M. U. Galy B. Camaschella C. (2010 ). Two to tango: regulation of mammalian iron metabolism. Cell 142 24–38

    Not in our library10.1016/j.cell.2010.06.028

  54. 54.

    Hood M. I. Skaar E. P. (2012 ). Nutritional immunity: transition metals at the pathogen–host interface. Nat. Rev. Microbiol. 10 525–537

    Not in our library10.1038/nrmicro2836

  55. 55.

    Ibrahim A. S. Gebermariam T. Fu Y. Lin L. Husseiny M. I. French S. W. (2007 ). The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J. Clin. Invest. 117 2649–2657

    Not in our library10.1172/jci32338

  56. 56.

    Isanaka S. Aboud S. Mugusi F. Bosch R. J. Willett W. C. Spiegelman D. (2012a ). Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS ONE 7:e37350

    Not in our library10.1371/journal.pone.0037350

  57. 57.

    Isanaka S. Mugusi F. Urassa W. Willett W. C. Bosch R. J. Villamor E. (2012b ). Iron deficiency and anemia predict mortality in patients with tuberculosis. J. Nutr. 142 350–357

    Not in our library10.3945/jn.111.144287

  58. 58.

    Johnson D. Bayele H. Johnston K. Tennant J. Srai S. K. Sharp P. (2004 ). Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett. 573 195–201

    Not in our library10.1016/j.febslet.2004.07.081

  59. 59.

    Jonker F. A. Calis J. C. Phiri K. Kraaijenhagen R. J. Brabin B. J. Faragher B. (2013 ). Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS ONE 8:e78964

    Not in our library10.1371/journal.pone.0078964

  60. 60.

    Kabyemela E. R. Fried M. Kurtis J. D. Mutabingwa T. K. Duffy P. E. (2008 ). Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J. Infect. Dis. 198 163–166

    Not in our library10.1086/589512

  61. 61.

    Kemna E. Pickkers P. Nemeth E. van der Hoeven H. Swinkels D. (2005 ). Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 1864–1866

    Not in our library10.1182/blood-2005-03-1159

  62. 62.

    Kim D. K. Jeong J. H. Lee J. M. Kim K. S. Park S. H. Kim Y. D. (2014 ). Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20 419–424

    Not in our library10.1038/nm.3483

  63. 63.

    Knutson M. D. Oukka M. Koss L. M. Aydemir F. Wessling-Resnick M. (2005 ). Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. U.S.A. 102 1324–1328

    Not in our library10.1073/pnas.0409409102

  64. 64.

    Koskenkorva-Frank T. S. Weiss G. Koppenol W. H. Burckhardt S. (2013 ). The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic. Biol. Med. 65 1174–1194

    Not in our library10.1016/j.freeradbiomed.2013.09.001

  65. 65.

    Kuhn D. E. Lafuse W. P. Zwilling B. S. (2001 ). Iron transport into Mycobacterium avium-containing phagosomes from an Nramp1(Gly169)-transfected RAW264.7 macrophage cell line. J. Leukoc. Biol. 69 43–49

    Not in our library

  66. 66.

    Liu Z. Reba S. Chen W. D. Porwal S. K. Boom W. H. Petersen R. B. (2014 ). Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J. Exp. Med. 211 1197–213

    Not in our library10.1084/jem.20132629

  67. 67.

    Ludwiczek S. Aigner E. Theurl I. Weiss G. (2003 ). Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101 4148–4154

    Not in our library10.1182/blood-2002-08-2459

  68. 68.

    Mabeza G. F. Loyevsky M. Gordeuk V. R. Weiss G. (1999 ). Iron chelation therapy for malaria: a review. Pharmacol. Ther. 81 53–75

    Not in our library10.1016/s0163-7258(98)00037-0

  69. 69.

    Mair S. M. Nairz M. Bellmann-Weiler R. Muehlbacher T. Schroll A. Theurl I. (2011 ). Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis. J. Infect. Dis. 204 685–694

    Not in our library10.1093/infdis/jir395

  70. 70.

    Mastroeni P. Vazquez-Torres A. Fang F. C. Xu Y. Khan S. Hormaeche C. E. (2000 ). Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental Salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192 237–248

    Not in our library10.1084/jem.192.2.237

  71. 71.

    McCollister B. D. Bourret T. J. Gill R. Jones-Carson J. Vazquez-Torres A. (2005 ). Repression of SPI2 transcription by nitric oxide-producing, IFNgamma-activated macrophages promotes maturation of Salmonella phagosomes. J. Exp. Med. 202 625–635

    Not in our library10.1084/jem.20050246

  72. 72.
    Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study · 2013
    Not checked
  73. 73.

    Melillo G. Taylor L. S. Brooks A. Musso T. Cox G. W. Varesio L. (1997 ). Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272 12236–12243

    Not in our library10.1074/jbc.272.18.12236

  74. 74.

    Mencacci A. Cenci E. Boelaert J. R. Bucci P. Mosci P. Fe d’Ostiani C. (1997 ). Iron overload alters innate and T helper cell responses to Candida albicans in mice. J. Infect. Dis. 175 1467–1476

    Not in our library10.1086/516481

  75. 75.

    Mittra B. Cortez M. Haydock A. Ramasamy G. Myler P. J. Andrews N. W. (2013 ). Iron uptake controls the generation of Leishmania infective forms through regulation of ROS levels. J. Exp. Med. 210 401–416

    Not in our library10.1084/jem.20121368

  76. 76.

    Moyo V. M. Gangaidzo I. T. Gordeuk V. R. Kiire C. F. Macphail A. P. (1997 ). Tuberculosis and iron overload in Africa: a review. Cent. Afr. J. Med. 43 334–339

    Not in our library

  77. 77.

    Mulero V. Brock J. H. (1999 ). Regulation of iron metabolism in murine J774 macrophages: role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide. Blood 94 2383–2389

    Not in our library

  78. 78.

    Nairz M. Fritsche G. Brunner P. Talasz H. Hantke K. Weiss G. (2008 ). Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 38 1923–1936

    Not in our library10.1002/eji.200738056

  79. 79.

    Nairz M. Fritsche G. Crouch M. L. Barton H. C. Fang F. C. Weiss G. (2009a ). Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell Microbiol. 11 1365–1381

    Not in our library10.1111/j.1462-5822.2009.01337.x

  80. 80.

    Nairz M. Theurl I. Schroll A. Theurl M. Fritsche G. Lindner E. (2009b ). Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114 3642–3651

    Not in our library10.1182/blood-2009-05-223354

  81. 81.

    Nairz M. Schleicher U. Schroll A. Sonnweber T. Theurl I. Ludwiczek S. (2013 ). Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210 855–873

    Not in our library10.1084/jem.20121946

  82. 82.

    Nairz M. Schroll A. Moschen A. R. Sonnweber T. Theurl M. Theurl I. (2011 ). Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways. Immunity 34 61–74

    Not in our library10.1016/j.immuni.2011.01.002

  83. 83.

    Nairz M. Schroll A. Sonnweber T. Weiss G. (2010 ). The struggle for iron–a metal at the host–pathogen interface. Cell Microbiol. 12 1691–1702

    Not in our library10.1111/j.1462-5822.2010.01529.x

  84. 84.

    Nairz M. Theurl I. Ludwiczek S. Theurl M. Mair S. M. Fritsche G. (2007 ). The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 9 2126–2140

    Not in our library10.1111/j.1462-5822.2007.00942.x

  85. 85.

    Nathan C. Shiloh M. U. (2000 ). Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. U.S.A. 97 8841–8848

    Not in our library10.1073/pnas.97.16.8841

  86. 86.

    Nemeth E. Rivera S. Gabayan V. Keller C. Taudorf S. Pedersen B. K. (2004a ). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 1271–1276

    Not in our library10.1172/jci200420945

  87. 87.

    Nemeth E. Tuttle M. S. Powelson J. Vaughn M. B. Donovan A. Ward D. M. (2004b ). Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 2090–2093

    Not in our library10.1126/science.1104742

  88. 88.

    Nemeth E. Valore E. V. Territo M. Schiller G. Lichtenstein A. Ganz T. (2003 ). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 2461–2463

    Not in our library10.1182/blood-2002-10-3235

  89. 89.

    Oexle H. Kaser A. Most J. Bellmann-Weiler R. Werner E. R. Werner-Felmayer G. (2003 ). Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 74 287–294

    Not in our library10.1189/jlb.0802420

  90. 90.

    Olakanmi O. Kesavalu B. Abdalla M. Y. Britigan B. E. (2013 ). Iron acquisition by Mycobacterium tuberculosis residing within myeloid dendritic cells. Microb. Pathog. 65 21–28

    Not in our library10.1016/j.micpath.2013.09.002

  91. 91.

    Olakanmi O. Schlesinger L. S. Britigan B. E. (2007 ). Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J. Leukoc. Biol. 81 195–204

    Not in our library10.1189/jlb.0606405

  92. 92.

    Oppenheimer S. J. (2001 ). Iron and its relation to immunity and infectious disease. J. Nutr. 131 616S–633S; discussion 633S–635S

    Not in our library10.1093/jn/131.2.616s

  93. 93.

    Paiva C. N. Feijo D. F. Dutra F. F. Carneiro V. C. Freitas G. B. Alves L. S. (2012 ). Oxidative stress fuels Trypanosoma cruzi infection in mice. J. Clin. Invest. 122 2531–2542

    Not in our library10.1172/jci58525

  94. 94.

    Pantopoulos K. Porwal S. K. Tartakoff A. Devireddy L. (2012 ). Mechanisms of mammalian iron homeostasis. Biochemistry 51 5705–5724

    Not in our library10.1021/bi300752r

  95. 95.

    Pantopoulos K. Weiss G. Hentze M. W. (1996 ). Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol. Cell. Biol. 16 3781–3788

    Not in our library10.1128/mcb.16.7.3781

  96. 96.

    Papanikolaou G. Pantopoulos K. (2005 ). Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 199–211

    Not in our library10.1016/j.taap.2004.06.021

  97. 97.

    Paradkar P. N. De Domenico I. Durchfort N. Zohn I. Kaplan J. Ward D. M. (2008 ). Iron depletion limits intracellular bacterial growth in macrophages. Blood 112 866–874

    Not in our library10.1182/blood-2007-12-126854

  98. 98.

    Peyssonnaux C. Zinkernagel A. S. Datta V. Lauth X. Johnson R. S. Nizet V. (2006 ). TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107 3727–3732

    Not in our library10.1182/blood-2005-06-2259

  99. 99.

    Pietrangelo A. (2004 ). Hereditary hemochromatosis–a new look at an old disease. N. Engl. J. Med. 350 2383–2397

    Not in our library10.1056/nejmra031573

  100. 100.

    Porto G. De Sousa M. (2007 ). Iron overload and immunity. World J. Gastroenterol. 13 4707–4715

    Not in our library10.3748/wjg.v13.i35.4707

  101. 101.

    Portugal S. Carret C. Recker M. Armitage A. E. Goncalves L. A. Epiphanio S. (2011 ). Host-mediated regulation of superinfection in malaria. Nat. Med. 17 732–737

    Not in our library10.1038/nm.2368

  102. 102.

    Prentice A. M. Doherty C. P. Abrams S. A. Cox S. E. Atkinson S. H. Verhoef H. (2012 ). Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 119 1922–1928

    Not in our library10.1182/blood-2011-11-391219

  103. 103.

    Prentice A. M. Verhoef H. Cerami C. (2013 ). Iron fortification and malaria risk in children. J. Am. Med. Assoc. 310 914–915

    Not in our library10.1001/jama.2013.6771

  104. 104.

    Rabsch W. Voigt W. Reissbrodt R. Tsolis R. M. Baumler A. J. (1999 ). Salmonella typhimurium IroN and FepA proteins mediate uptake of enterobactin but differ in their specificity for other siderophores. J. Bacteriol. 181 3610–3612

    Not in our library10.1128/jb.181.11.3610-3612.1999

  105. 105.

    Raffatellu M. George M. D. Akiyama Y. Hornsby M. J. Nuccio S. P. Paixao T. A. (2009 ). Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5 476–486

    Not in our library10.1016/j.chom.2009.03.011

  106. 106.

    Rafiee A. Riazi-Rad F. Darabi H. Khaze V. Javadian S. Ajdary S. (2014 ). Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major. Int. J. Pharm. 466 375–381

    Not in our library10.1016/j.ijpharm.2014.03.039

  107. 107.

    Roy C. N. Mak H. H. Akpan I. Losyev G. Zurakowski D. Andrews N. C. (2007 ). Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 109 4038–4044

    Not in our library10.1182/blood-2006-10-051755

  108. 108.

    Sazawal S. Black R. E. Ramsan M. Chwaya H. M. Stoltzfus R. J. Dutta A. (2006 ). Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367 133–143

    Not in our library10.1016/s0140-6736(06)67962-2

  109. 109.

    Schaible U. E. Kaufmann S. H. (2004 ). Iron and microbial infection. Nat. Rev. Microbiol. 2 946–953

    Not in our library10.1038/nrmicro1046

  110. 110.

    Schnappinger D. Ehrt S. Voskuil M. I. Liu Y. Mangan J. A. Monahan I. M. (2003 ). Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198 693–704

    Not in our library10.1084/jem.20030846

  111. 111.

    Schrettl M. Bignell E. Kragl C. Joechl C. Rogers T. Arst H. N. Jr. (2004 ). Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J. Exp. Med. 200 1213–1219

    Not in our library10.1084/jem.20041242

  112. 112.

    Schumann K. Ettle T. Szegner B. Elsenhans B. Solomons N. W. (2007 ). On risks and benefits of iron supplementation recommendations for iron intake revisited. J. Trace Elem. Med. Biol. 21 147–168

    Not in our library10.1016/j.jtemb.2007.06.002

  113. 113.

    Sen G. Mukhopadhyay S. Ray M. Biswas T. (2008 ). Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J. Antimicrob. Chemother. 61 1066–1075

    Not in our library10.1093/jac/dkn053

  114. 114.

    Soe-Lin S. Apte S. S. Andriopoulos B. Jr. Andrews M. C. Schranzhofer M. Kahawita T. (2009 ). Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl. Acad. Sci. U.S.A. 106 5960–5965

    Not in our library10.1073/pnas.0900808106

  115. 115.

    Sohn Y. S. Mitterstiller A. M. Breuer W. Weiss G. Cabantchik Z. I. (2011 ). Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal. Br. J. Pharmacol. 164 406–418

    Not in our library10.1111/j.1476-5381.2010.01120.x

  116. 116.

    Soofi S. Cousens S. Iqbal S. P. Akhund T. Khan J. Ahmed I. (2013 ). Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet 382 29–40

    Not in our library10.1016/s0140-6736(13)60437-7

  117. 117.

    Spees A. M. Kingsbury D. D. Wangdi T. Xavier M. N. Tsolis R. M. Baumler A. J. (2014 ). Neutrophils are a source of gamma interferon during acute Salmonella enterica Serovar Typhimurium colitis. Infect. Immun. 82 1692–1697

    Not in our library10.1128/iai.01508-13

  118. 118.

    Spellberg B. Ibrahim A. S. Chin-Hong P. V. Kontoyiannis D. P. Morris M. I. Perfect J. R. (2012 ). The Deferasirox-AmBisome therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J. Antimicrob. Chemother. 67 715–722

    Not in our library10.1093/jac/dkr375

  119. 119.

    Spivak J. L. (2002 ). Iron and the anemia of chronic disease. Oncology (Huntingt.) 16 25–33

    Not in our library

  120. 120.

    Srinivasan G. Aitken J. D. Zhang B. Carvalho F. A. Chassaing B. Shashidharamurthy R. (2012 ). Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J. Immunol. 189 1911–1919

    Not in our library10.4049/jimmunol.1200892

  121. 121.

    Stijlemans B. Vankrunkelsven A. Brys L. Magez S. De Baetselier P. (2008 ). Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology 213 823–835

    Not in our library10.1016/j.imbio.2008.07.023

  122. 122.

    Stijlemans B. Vankrunkelsven A. Brys L. Raes G. Magez S. De Baetselier P. (2010 ). Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis. Microbes Infect. 12 389–399

    Not in our library10.1016/j.micinf.2010.02.006

  123. 123.

    Taylor M. C. Kelly J. M. (2010 ). Iron metabolism in trypanosomatids, and its crucial role in infection. Parasitology 137 899–917

    Not in our library10.1017/s0031182009991880

  124. 124.

    Theurl I. Aigner E. Theurl M. Nairz M. Seifert M. Schroll A. (2009 ). Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113 5277–5286

    Not in our library10.1182/blood-2008-12-195651

  125. 125.

    Theurl I. Mattle V. Seifert M. Mariani M. Marth C. Weiss G. (2006 ). Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 107 4142–4148

    Not in our library10.1182/blood-2005-08-3364

  126. 126.

    Theurl I. Theurl M. Seifert M. Mair S. Nairz M. Rumpold H. (2008 ). Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111 2392–2399

    Not in our library10.1182/blood-2007-05-090019

  127. 127.

    Thomas C. Thomas L. (2005 ). Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab. Hematol. 11 14–23

    Not in our library10.1532/lh96.04049

  128. 128.

    Thorson J. A. Smith K. M. Gomez F. Naumann P. W. Kemp J. D. (1991 ). Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol. 134 126–137

    Not in our library10.1016/0008-8749(91)90336-a

  129. 129.

    Thuma P. E. Weiss G. Herold M. Gordeuk V. R. (1996 ). Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy. Am. J. Trop. Med. Hyg. 54 164–168

    Not in our library10.4269/ajtmh.1996.54.164

  130. 130.

    Tilg H. Ulmer H. Kaser A. Weiss G. (2002 ). Role of IL-10 for induction of anemia during inflammation. J. Immunol. 169 2204–2209

    Not in our library10.4049/jimmunol.169.4.2204

  131. 131.

    Vale-Costa S. Gomes-Pereira S. Teixeira C. M. Rosa G. Rodrigues P. N. Tomas A. (2013 ). Iron overload favors the elimination of Leishmania infantum from mouse tissues through interaction with reactive oxygen and nitrogen species. PLoS Negl. Trop. Dis. 7:e2061

    Not in our library10.1371/journal.pntd.0002061

  132. 132.

    Van Zandt K. E. Sow F. B. Florence W. C. Zwilling B. S. Satoskar A. R. Schlesinger L. S. (2008 ). The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J. Leukoc. Biol. 84 689–700

    Not in our library10.1189/jlb.1107781

  133. 133.

    Vecchi C. Montosi G. Zhang K. Lamberti I. Duncan S. A. Kaufman R. J. (2009 ). ER stress controls iron metabolism through induction of hepcidin. Science 325 877–880

    Not in our library10.1126/science.1176639

  134. 134.

    Wang L. Harrington L. Trebicka E. Shi H. N. Kagan J. C. Hong C. C. (2009 ). Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J. Clin. Invest. 119 3322–3328 Epub 2009 Oct 5

    Not in our library10.1172/jci39939

  135. 135.

    Warszawska J. M. Gawish R. Sharif O. Sigel S. Doninger B. Lakovits K. (2013 ). Lipocalin 2 deactivates macrophages and worsens Pneumococcal pneumonia outcomes. J. Clin. Invest. 123 3363–3372

    Not in our library10.1172/jci67911

  136. 136.

    Weinberg E. D. (2009 ). Iron availability and infection. Biochim. Biophys. Acta 1790 600–605

    Not in our library10.1016/j.bbagen.2008.07.002

  137. 137.

    Weiss G. (2002 ). Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 32(Suppl. 1) 70–78

    Not in our library10.1046/j.1365-2362.2002.0320s1070.x

  138. 138.

    Weiss G. Bogdan C. Hentze M. W. (1997a ). Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 158 420–425

    Not in our library

  139. 139.

    Weiss G. Thuma P. E. Mabeza G. Werner E. R. Herold M. Gordeuk V. R. (1997b ). Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J. Infect. Dis. 175 226–230

    Not in our library10.1093/infdis/175.1.226

  140. 140.

    Weiss G. Fuchs D. Hausen A. Reibnegger G. Werner E. R. Werner-Felmayer G. (1992 ). Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 20 605–610

    Not in our library

  141. 141.

    Weiss G. Goodnough L. T. (2005 ). Anemia of chronic disease. N. Engl. J. Med. 352 1011–1023

    Not in our library10.1056/nejmra041809

  142. 142.

    Weiss G. Goossen B. Doppler W. Fuchs D. Pantopoulos K. Werner-Felmayer G. (1993 ). Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12 3651–3657

    Not in our library10.1002/j.1460-2075.1993.tb06039.x

  143. 143.

    Weiss G. Schett G. (2013 ). Anaemia in inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 9 205–215

    Not in our library10.1038/nrrheum.2012.183

  144. 144.

    Weiss G. Werner-Felmayer G. Werner E. R. Grunewald K. Wachter H. Hentze M. W. (1994 ). Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180 969–976

    Not in our library10.1084/jem.180.3.969

  145. 145.

    Winkelmann G. (2002 ). Microbial siderophore-mediated transport. Biochem. Soc. Trans. 30 691–696

    Not in our library10.1042/bst0300691

  146. 146.

    Yang F. Liu X. B. Quinones M. Melby P. C. Ghio A. Haile D. J. (2002 ). Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277 39786–39791

    Not in our library10.1074/jbc.m201485200

  147. 147.

    Zlotkin S. Newton S. Aimone A. M. Azindow I. Amenga-Etego S. Tchum K. (2013 ). Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. J. Am. Med. Assoc. 310 938–947

    Not in our library10.1001/jama.2013.277129

  148. 148.

    Zwilling B. S. Kuhn D. E. Wikoff L. Brown D. Lafuse W. (1999 ). Role of iron in Nramp1-mediated inhibition of Mycobacterial growth. Infect. Immun. 67 1386–1392

    Not in our library10.1128/iai.67.3.1386-1392.1999

Cited by papers we hold 15

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.